Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

TREATMENT OF HUNTINGTON'S CHOREA WITH BROMOCRIPTINE

2009; Wiley; Volume: 56; Issue: 1 Linguagem: Inglês

10.1111/j.1600-0404.1977.tb01407.x

ISSN

1600-0404

Autores

L. Frattola, M. G. Albizzati, PierFranco Spano, Marco Trabucchi,

Tópico(s)

Botulinum Toxin and Related Neurological Disorders

Resumo

The authors tested the effects of 2-Br-ergocriptine (bromocriptine, CB-154), a drug which exerts a mixed agonist-antagonist activity on the dopaminergic receptors, in 12 patients with Huntinton Chorea in a double-blind crossover trial. This treatment significantly reduced the abnormal involuntary movements and the disease severity in most of the patients. Subjects who were slightly disabled showed a better response than the ones with more severe degrees of disability.

Referência(s)